Public Sector Pension Investment Board Revance Therapeutics, Inc. Transaction History

Public Sector Pension Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $778,540 - $1.5 Million	-134,000 Reduced 76.14%	42,000 $369,000
Q3 2023 Nov 22, 2023	SELL	$11.47 - $25.07 $894,660 - $1.96 Million	-78,000 Reduced 30.71%	176,000 $2.02 Million
Q1 2023 May 12, 2023	BUY	$18.36 - $35.27 $2.2 Million - $4.23 Million	120,000 Added 89.55%	254,000 $8.18 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $2.45 Million - $4.11 Million	134,000 New	134,000 $2.47 Million
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $610,540 - $1.37 Million	-49,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$25.78 - $33.21 $1.26 Million - $1.63 Million	49,000 New	49,000 $1.37 Million

232

83.2M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.